MarketsStocksGLAXO
GL

GLAXOSMITHKLINE PHARMA LT

NSE: GLAXOBSE: 500660Healthcare
Download Research Report7-page PDF
2,183.00
+0.87%
NSE · auto-updates while market open
Prev Close
₹3,438.50
Day High
₹2,189.90
Day Low
₹2,142.00
Mkt Cap
₹37,078 Cr
P / E
35.8
P / B
16.4
ROE
49.1%
52W High
₹3,515.70
52W Low
₹2,154.00
Key Metrics
Market Cap
₹37,078 Cr
P / E
35.79
P / B
16.36
EV / EBITDA
26.52
ROCE
66.8%
ROE
49.1%
Debt / Equity
0.00
Book Value
₹133.84
EPS
₹54.52
Div Yield
2.6%
Face Value
₹10
Promoter Holding
75.0%
Revenue · ₹ Cr
3.2k
FY20
3.2k
FY21
3.3k
FY22
3.3k
FY23
3.5k
FY24
3.7k
FY25
3.8k
FY26
Net Profit · ₹ Cr
93
FY20
358
FY21
1.7k
FY22
611
FY23
590
FY24
928
FY25
1.0k
FY26
EPS · ₹ per share
₹5.5
FY20
₹21.1
FY21
₹100.0
FY22
₹36.0
FY23
₹34.8
FY24
₹54.5
FY25
₹54.5
FY26
P / E Ratio · price ÷ TTM EPS
6325986114530-8Jun 21Feb 23Oct 24Jun 26
P/E 36.3×Median 46.6×TTM EPS
Q1 2026 snapshot
Sales
₹1.03K Cr
Operating profit
-
OPM
-
Net profit
₹278 Cr
EPS
₹16.40
Scorecard · 7 axes
Quality
Good
73/100
Valuation
Avg
35.8×
Growth
Bad
-3.8%
Profitability
Strong
58.0%
Performance
Bad
-37.6%
Entry Point
Good
62%
Red Flags
Strong
0 flags
Shareholding Pattern
75.0%Promoter
Promoter75.0%
FII4.6%
DII7.7%
Public12.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue949.421,015.05848.891,013.511,073.381,031.25
Net Profit229.88262.87205.01257.49295.62277.86
NPM %24.2%25.9%24.2%25.4%27.5%26.9%
AlertPre-trade